| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 03/08/2006 | EP1632494A1 Vasopressin v1a antagonists |
| 03/08/2006 | EP1632483A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 03/08/2006 | EP1632482A1 Intermediates and process for the production of optically active quinolonecarboxylic acid derivatives |
| 03/08/2006 | EP1632477A1 Benzamide derivative or salt thereof |
| 03/08/2006 | EP1632470A2 Calcium receptor active molecules |
| 03/08/2006 | EP1631565A1 Piperazine-alkyl-ureido derivatives |
| 03/08/2006 | EP1631562A1 Chromene derivatives as anti-inflammatory agents |
| 03/08/2006 | EP1631550A1 An improved method for the preparation of montelukast acid and sodium salt thereof in amorphous form |
| 03/08/2006 | EP1631542A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 03/08/2006 | EP1482924A4 Cathepsin cysteine protease inhibitors |
| 03/08/2006 | EP1451167B1 Phenylalkynes |
| 03/08/2006 | EP1406628B1 Tetrahydroquinoline derivatives |
| 03/08/2006 | EP1318995B1 Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
| 03/08/2006 | EP1313721B1 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 03/08/2006 | EP1198454B1 Mutilin derivatives and their use as antibacterials |
| 03/08/2006 | EP1178967B1 Quinoline derivatives as inhibitors of mek enzymes |
| 03/08/2006 | CN1745076A Malonamide derivatives as gamma-secretase inhibitors |
| 03/08/2006 | CN1244582C Compound of quinolone carboxylic acid, preparation method and medicinal usage |
| 03/08/2006 | CN1244577C 4-phenyl-peiperazinyl,-piperidinyl and -tetrahydropyridyl derivatives |
| 03/08/2006 | CN1244575C Sulfonyl alkylamido hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 03/08/2006 | CN1244565C New asymmetric process for preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
| 03/08/2006 | CN1244543C Method for preparing 4-(alkyl)-3-alkoxy-aniline compounds |
| 03/07/2006 | US7009055 Preparation of Sulfonyl quinoline |
| 03/07/2006 | US7009054 Quinolines and uses thereof |
| 03/07/2006 | US7009053 Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same |
| 03/07/2006 | US7009052 such as 1-methyl-2-oxo-4-trifluoromethyl-1,2-dihydroquinoline-6-sulfonic acid phenylamide for use as androgen antagonists |
| 03/07/2006 | US7008951 Such as asthma or chronic obstructive pulmonary disease; mixture of a corticoid such as budesonide, fluticasone propionate or mometasone furoate and 5-(1-hydroxy-2-((5,6-diethylindan-2-yl)amino)ethyl)8-hydroxy-1,2-dihydroquinolin-2-one or its salt |
| 03/02/2006 | WO2006021974A1 A process for synthesizing diol (viii)-an intermediate of montelukast sodium |
| 03/02/2006 | WO2006021565A1 Novel substituted heteroaryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/02/2006 | WO2006021213A2 Vasopressin v1a antagonists |
| 03/02/2006 | WO2005113542A3 N-cyclic sulfonamido inhibitors of gamma secretase |
| 03/02/2006 | WO2005105749A3 Process for making montelukast and intermediates therefor |
| 03/02/2006 | DE102004041163A1 Neue Verbindungen mit antibakterieller Aktivität New compounds with antibacterial activity |
| 03/02/2006 | CA2689274A1 Vasopressin via antagonists |
| 03/02/2006 | CA2688912A1 Vasopressin v1a antagonists |
| 03/02/2006 | CA2688865A1 Vasopressin v1a antagonists |
| 03/02/2006 | CA2577100A1 Chemical compounds |
| 03/01/2006 | EP1628985A2 Chiral ligands and their transition metal complexes |
| 03/01/2006 | EP1628961A1 Phenyl quinolines and their use as estrogen receptor modulators |
| 03/01/2006 | EP1572657A4 Processes for preparing quinolonecarboxylate derivatives |
| 03/01/2006 | CN1741998A Blue emitting tris (8-oxoquinoline) aluminum (III) (Alq3) |
| 03/01/2006 | CN1741990A Arylalkylcarbamate derivatives production and use thereof in therapy |
| 03/01/2006 | CN1741986A Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 03/01/2006 | CN1741984A CaSR antagonist |
| 03/01/2006 | CN1740170A Prepn process of peptide HIV proteinase inhibitor |
| 03/01/2006 | CN1243741C Quinolinyl and benzothiazolyc PPAR-gamma modulators |
| 03/01/2006 | CN1243724C Amide derivatives which are useful as cell factor inhibitors |
| 03/01/2006 | CN1243723C N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors for FSAD |
| 02/28/2006 | US7005538 N-[3,5-Dibromo-4-(3-bromobenzyloxy)benzoyl]benzenesulphonamide for example; use to treat cardiac arrhythmias, thyrotoxicosis and subclinical hyperthyroidism |
| 02/28/2006 | US7005440 Therapeutic uses of tri-aryl acid derivatives |
| 02/23/2006 | WO2005115145A3 Quinone substituted quinazoline and quinoline kinase inhibitors |
| 02/23/2006 | WO2005110980A3 Aryl sulfones and uses related thereto |
| 02/23/2006 | WO2005077903A3 Melanin concentrating hormone receptor ligands: substituted tetrahydroisoquinoline analogues |
| 02/23/2006 | WO2005048953A3 Amide derivatives as kinase modulators |
| 02/23/2006 | WO2005003086A3 Sulfonic acid derivatives of polycyclic dyes used for analytical applications |
| 02/23/2006 | US20060040949 Treating antibiotic resistant bacterial infections; compounds based on quinoline rings; (3S)-2-(3-{[(Benzo[1,2,5]thiadiazol-5-ylmethyl)-amino]-methyl}-piperidin-1-yl)-(1RS)-(6-methoxy-quinolin-4-yl)-ethanol for example |
| 02/23/2006 | US20060040925 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity |
| 02/23/2006 | CA2581327A1 Intracellular receptor modulator compounds and methods |
| 02/23/2006 | CA2575560A1 Chemical compounds |
| 02/22/2006 | EP1627880A1 Boronic ester and acid compounds, synthesis and uses |
| 02/22/2006 | EP1627869A1 Amide derivative |
| 02/22/2006 | EP1385839B1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 02/22/2006 | EP1224187B1 Certain alkylene diamine-substituted heterocycles |
| 02/22/2006 | CN1738807A Substituted aralkyl derivatives |
| 02/22/2006 | CN1738802A Antibiotics containing borinic acid complexes and methods of use |
| 02/22/2006 | CN1738799A Methods for preparing phenylalkyne derivatives |
| 02/22/2006 | CN1738797A Substituted aryl thioureas and related compounds; inhibitors of viral replication |
| 02/22/2006 | CN1736981A Selective androgen receptor modulators and methods of use thereof |
| 02/22/2006 | CN1736371A Selective androgen receptor modulators and methods of use thereof |
| 02/22/2006 | CN1243000C Tocopherols, tocotrienols, other chroman and side chain dervative and uses thereof |
| 02/22/2006 | CN1242993C Heterocycle derivatives and drugs |
| 02/22/2006 | CN1242975C Method of producing carboxylic acid salts |
| 02/21/2006 | US7002022 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration |
| 02/21/2006 | CA2250347C Piperazine and piperidine compounds with high affinity for dopamine-d2 and serotonin-5ht1a receptors |
| 02/21/2006 | CA2239970C Process for preparing optically active compounds |
| 02/16/2006 | WO2006015870A1 Tetrahydro-naphthalene derivatives as glucocorticoid receptor modulators |
| 02/16/2006 | WO2005097137A3 Advanced quinazoline based protein kinase inhibitors |
| 02/16/2006 | WO2005080317A3 Therapeutic amide derivatives |
| 02/16/2006 | WO2005055941A3 Novel m3 muscarinic acetylcholine receptor antagonists |
| 02/16/2006 | US20060036096 Process for producing quinolinecarbaldehyde |
| 02/16/2006 | US20060035925 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 02/16/2006 | US20060035884 N-cyclic sulfonamido inhibitors of gamma secretase |
| 02/16/2006 | US20060035870 Carboxylic acid derivatives as IP antagonists |
| 02/16/2006 | DE102004035203A1 Substituierte Chinolone Substituted Quinolones |
| 02/16/2006 | DE102004033405A1 New 7-phenylamino-quinolone or 1,8-naphthyridone derivatives, useful e.g. for treating type II diabetes or arteriosclerosis, are inhibitors of glycogen phosphorylase |
| 02/16/2006 | CA2573509A1 Histone deacetylase inhibitors |
| 02/15/2006 | EP1008346B1 NF-kB INHIBITORS CONTAINING BENZOQUINONE DERIVATIVES |
| 02/15/2006 | CN1735612A Anti-infective agents |
| 02/15/2006 | CN1735601A Combination products with carboxylic acid derivatives that inhibit the binding of integrins to their receptors and other therapeutic compounds |
| 02/15/2006 | CN1735599A 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands |
| 02/15/2006 | CN1735416A Therapeutic combination |
| 02/15/2006 | CN1241914C Method for preparing 7-quinolinyl-3, 5-dihydroxyhept-6-enoate |
| 02/15/2006 | CN1241909C Carboxylic acid derivatives as IP antagonists |
| 02/14/2006 | US6998423 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents; |
| 02/14/2006 | CA2363145C Oxamic acids and derivatives as thyroid receptor ligands |
| 02/14/2006 | CA2241094C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 02/14/2006 | CA2241093C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 02/09/2006 | WO2006014134A1 Novel piperidine derivative for the treatment of depression |
| 02/09/2006 | WO2006013896A1 Quinoline derivative and insecticide containing same as active constituent |
| 02/09/2006 | WO2006013394A1 Quinoline derivatives as neurokinin receptor antagonists |